O-017 A Phase I/II trial of erlotinib (ERLO) in higher-risk MDS after azacitidine (AZA) failure

✍ Scribed by Thepot, S.; Boehrer, S.; Prebet, T.; Beyne-Rauzy, O.; Wattel, E.; Delaunay, J.; Raffoux, E.; Schmidt, A.L.; Wickenhauser, S.; Dreyfus, F.; Fenaux, P.; Adès, L.

• Book ID: 122528463
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 88 KB
• Volume: 37
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/S0145-2126(13)70039-0